Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 19/20 | 0.85 |
| ▸ | HDAC1 | Q13547 | 19/20 | 0.85 |
| ▸ | HDAC11 | Q96DB2 | 19/20 | 0.85 |
| ▸ | HDAC8 | Q9BY41 | 19/20 | 0.85 |
| ▸ | HDAC6 | Q9UBN7 | 19/20 | 0.85 |
| ▸ | HDAC5 | Q9UQL6 | 19/20 | 0.85 |
| ▸ | HDAC7 | Q8WUI4 | 18/20 | 0.85 |
| ▸ | HDAC9 | Q9UKV0 | 18/20 | 0.85 |
| ▸ | HDAC3 | O15379 | 18/20 | 0.85 |
| ▸ | HDAC2 | Q92769 | 18/20 | 0.85 |
| ▸ | HDAC10 | Q969S8 | 18/20 | 0.85 |
| ▸ | NCOR1 | O75376 | 2/20 | 0.85 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.85 |
| ▸ | BRD4 | O60885 | 1/20 | 0.85 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.85 |
| ▸ | EGFR | P00533 | 1/20 | 0.85 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.85 |
| ▸ | LTA4H | P09960 | 1/20 | 0.85 |
| ▸ | NR0B1 | P51843 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6665592 | 1.00 | HDAC4 (0.85) | HDAC4HDAC1HDAC11HDAC8HDAC6 | |
| SCHEMBL6669511 | 1.00 | HDAC4 (0.85) | HDAC4HDAC1HDAC11HDAC8HDAC6 | |
| SCHEMBL1065393 | 1.00 | HDAC4 (0.85) | HDAC4HDAC1HDAC11HDAC8HDAC6 | |
| SCHEMBL517309 | 0.98 | HDAC4 (0.81) | HDAC4HDAC1HDAC11HDAC8HDAC6 | |
| Hydroxyamine SCHEMBL1268824 | 0.96 | HDAC6 (0.79) | HDAC4HDAC1HDAC11HDAC8HDAC6 | |
| SCHEMBL1064861 | 0.94 | HDAC4 (0.77) | HDAC4HDAC1HDAC11HDAC8HDAC6 | |
| SCHEMBL312344 | 0.94 | HDAC4 (0.77) | HDAC4HDAC1HDAC11HDAC8HDAC6 | |
| SCHEMBL6296181 | 0.93 | HDAC4 (0.75) | HDAC4HDAC1HDAC11HDAC8HDAC6 | |
| SCHEMBL23055010 | 0.92 | HDAC1 (1.00) | HDAC4HDAC1HDAC11HDAC8HDAC6 | |
| SCHEMBL4403514 | 0.92 | HDAC8 (0.74) | HDAC4HDAC1HDAC11HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 901 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024014643-A1 | METHOD FOR PRODUCING IMMUNOCYTES HAVING IMPROVED CYTOTOXICITY | 주식회사 노보셀바이오 | 2024-01-18 | — | — | WO | claimed |
| WO-2023201270-A2 | THERAPEUTIC APPLICATIONS OF CRISPR TYPE V SYSTEMS | CARIBOU BIOSCIENCES, INC. (US) | 2023-10-19 | — | — | WO | claimed |
| EP-3668867-B1 | SYNTHESIS, PHARMACOLOGY AND USE OF NEW AND SELECTIVE FMS-LIKE TYROSINE KINASE 3 (FLT3) FLT3 INHIBITORS | UNIV REGENSBURG (DE) | 2023-10-04 | — | — | EP | claimed |
| EP-3071040-B2 | METHOD FOR SCALABLE SKELETAL MUSCLE LINEAGE SPECIFICATION AND CULTIVATION | UNIV MISSOURI (US) | 2022-12-28 | — | — | EP | claimed |
| US-20210177760-A1 | DRUG DELIVERY COMPOSITION AND METHOD OF FABRICATION | DIGNITY HEALTH | 2021-06-17 | — | — | US | claimed |
| EP-2797898-B9 | PIPERAZINYL DERIVATIVES FOR THE TREATMENT OF CANCERS | PITTY MARC HENRY (FR) | 2021-05-26 | — | — | EP | claimed |
| WO-2021069690-A1 | FILM | THAI POLYETHYLENE CO., LTD. (TH) | 2021-04-15 | — | — | WO | claimed |
| EP-3283463-B1 | DIMERIC QUINACRINE DERIVATIVES AS AUTOPHAGY INHIBITORS FOR CANCER THERAPY | UNIV PENNSYLVANIA (US) | 2021-01-20 | — | — | EP | claimed |
| WO-2020231937-A1 | IRF2 AS A PROGNOSTIC BIOMARKER AND TARGET FOR AUGMENTING IMMUNOTHERAPY | UNIVERSITY OF MASSACHUSETTS (US) | 2020-11-19 | — | — | WO | claimed |
| EP-3328185-B1 | METHOD FOR PRODUCING HAPLOID, DIHAPLOID AND DOUBLED HAPLOID PLANTS BY ISOLATED MICROSPORE CULTURE | VILMORIN & CIE (FR) | 2020-06-24 | — | — | EP | claimed |
| JP-2007504131-A | — | — | 2007-03-01 | — | — | JP | claimed |
| EP-1667680-A2 | COMBINATION METHODS OF TREATING CANCER | Aton Pharma, Inc. (US) | 2006-06-14 | — | — | EP | claimed |
| EP-1545536-A2 | METHOD OF TREATING LEUKEMIA WITH A COMBINATION OF SUBEROYLANILIDE HYDROMAXIC ACID AND IMATINIB MESYLATE | UNIVERSITY OF SOUTH FLORIDA (US) | 2005-06-29 | — | — | EP | claimed |
| WO-2005023179-A2 | COMBINATION METHODS OF TREATING CANCER | ATON PHARMA, INC. (US) | 2005-03-17 | — | — | WO | claimed |
| EP-1297851-B1 | Inhibition of histone deacetylase as a treatment for cardiac hypertrophy | UNIV COLORADO (US) | 2005-01-26 | — | — | EP | claimed |
| US-20040127571-A1 | Method of Treating Leukemia with a Combination of Suberoylanilide Hydromaxic Acid and Imatinib Mesylate | UNIVERSITY OF SOUTH FLORIDA (US) | 2004-07-01 | — | — | US | claimed |
| WO-2004026234-A2 | METHOD OF TREATING LEUKEMIA WITH A COMBINATION OF SUBEROYLANILIDE HYDROMAXIC ACID AND IMATINIB MESYLATE | UNIVERSITY OF SOUTH FLORIDA (US) | 2004-04-01 | — | — | WO | claimed |
| WO-2002055017-A2 | METHOD OF TREATING AUTOIMMUNE DISEASES | WAKE FOREST UNIVERSITY (US) | 2002-07-18 | — | — | WO | claimed |
| US-6235823-B1 | CRYSTALLINE POLYPROPLYLENE RESIN AND A BETA-NUCLEATING AGENT, THE BETA-NUCLEATING AGENT BEING A DIAMIDE COMPOUND. | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2001-05-22 | — | — | US | claimed |
| EP-0557721-A2 | Crystalline polypropylene resin composition and amide compounds | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1993-09-01 | — | — | EP | claimed |